Who is sponsoring NCT03183466?

NCT03183466 is sponsored by Samsung Medical Center.

What drugs are being tested in NCT03183466?

Interventions in NCT03183466: arthroscopic repair, arthroscopic debridement.

What condition does NCT03183466 study?

NCT03183466 studies Subscapularis Tendon Tear, Arthroscopic Repair, Arthroscopic Debridement.

Is NCT03183466 still recruiting?

NCT03183466 is currently status unknown. Last updated 12 June 2017.

Last reviewed 2017-06-12 · How we verify

NCT03183466

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Do You Arthroscopic Repair for Subscapularis Tendon Tear, Which Accounts for More Than Half of the 1st Facet? Or do You Perform Debridement?

Status unknown NA Last updated 12 June 2017

What this trial tests

NA trial testing arthroscopic repair in Subscapularis Tendon Tear in 80 participants. Status unknown.

Timeline

1 December 2011

Primary endpoint
30 November 2014

1 July 2017

Quick facts

Lead sponsor	Samsung Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Primary purpose	treatment
Enrollment	80
Start date	1 December 2011
Primary completion	30 November 2014
Estimated completion	1 July 2017
Sites	1 location across South Korea

Drugs / interventions tested

arthroscopic repair
arthroscopic debridement

Conditions studied

Subscapularis Tendon Tear — all drugs for Subscapularis Tendon Tear →
Arthroscopic Repair — all drugs for Arthroscopic Repair →
Arthroscopic Debridement — all drugs for Arthroscopic Debridement →

Sponsor

Samsung Medical Center

Who can join

Eligibility, any sex, with Subscapularis Tendon Tear or Arthroscopic Repair. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to randomly classify the upper third of the subscapularis in 1/2 of the rupture patients as preoperative group (arthroscopic and arthroscopic debridement group) and the difference between clinical and clinical scores.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Surgery for rotator cuff tears.
Karjalainen TV, Jain NB, Jain NB, Heikkinen J, et al · · 2019 · cited 72× · PMID 31813166 · DOI 10.1002/14651858.cd013502
Prospective Randomized Clinical Trial of Arthroscopic Repair Versus Debridement for Partial Subscapularis Tendon Tears More Than Half of the Entire First Facet.
Jeong JY, Kim SC, Lee SM, Yoo JC. · · 2023 · cited 8× · PMID 37548022 · DOI 10.1177/03635465231187033

Verify or expand the search:

Other trials of arthroscopic repair

Trials testing the same drug.

NCT04951375 — Clinical Results of Arthroscopic Repair for Massive Rotator Cuff Tears of 14 Cases · completed
NCT04710966 — Comparison Between Arthroscopic Debridement and Repair for Partial-thickness Rotator Cuff Tears · NA · completed

Other Samsung Medical Center trials

Trials by the same sponsor.

NCT07482865 — Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support · NA · not yet recruiting
NCT07467213 — Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M · Phase 4 · not yet recruiting
NCT07530913 — Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients · NA · enrolling by invitation
NCT07500701 — Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro · Phase 3 · recruiting
NCT07409441 — Korea Acute Myocardial Infarction Registry · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03183466 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Samsung Medical Center
Last refreshed: 12 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03183466.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing